SavedAdd your journal

Journals / Marmara Pharmaceutical Journal / 2017 / Cilt: 21 - Sayı: 1

Karbonik anhidraz I ve II inhibitörü olan bazı N-(5-metil1,3,4-tiyadiazol-2-il)-4-[(3-sübstitüe)üreido/tiyoüreido] benzensülfonamitler

Some N-(5-methyl-1,3,4-thiadiazol-2-yl)-4-[(3-substituted)ureido/ thioureido]benzenesulfonamides as carbonic anhydrase I and II Inhibitors

SEVDA TÜRK
FATİH TOK
HÜLYA ÇELİK
SEVGİ KARAKUŞ
HAYRUNNİSA NADAROĞLU
Bedia KOÇYİĞİT KAYMAKÇIOĞLU
KAAN KÜÇÜKOĞLU
Pages
89–95
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Bileşiklerin klinikte kullanılan asetazolamide kıyasla insan sitozolik CA I (IC50 değerleri 0.144-15.65 nM) ve CA II (IC50 değerleri 0.109-17.95 nM) inhibisyon değerleri ile daha yüksek aktivite gösterdikleri tespit edildi.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Bu çalışmada N-(5-metil-1,3,4-tiyadiazol-2-il)-4-[(3-sübstitüe) üreido]benzensülfonamit ve N-(5-metil-1,3,4-tiyadiazol-2il)-4-[(3-sübstitüe)tiyoüreido]benzensülfonamit türevleri 4-amino-N-(5-metil-1,3,4-tiyadiazol-2-il)benzensülfonamitten (sülfametizol) hareketle sentez edildi.
📊
Key Findings & Data:Bütün yeni bileşiklerin yapıları elemental analiz ve çeşitli spektroskopik yöntemler (FTIR, 1H-NMR ve MS) yardımıyla aydınlatıldı.
💡
Conclusion & Impact:Bileşiklerin klinikte kullanılan asetazolamide kıyasla insan sitozolik CA I (IC50 değerleri 0.144-15.65 nM) ve CA II (IC50 değerleri 0.109-17.95 nM) inhibisyon değerleri ile daha yüksek aktivite gösterdikleri tespit edildi.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Bu çalışmada N-(5-metil-1,3,4-tiyadiazol-2-il)-4-[(3-sübstitüe) üreido]benzensülfonamit ve N-(5-metil-1,3,4-tiyadiazol-2il)-4-[(3-sübstitüe)tiyoüreido]benzensülfonamit türevleri 4-amino-N-(5-metil-1,3,4-tiyadiazol-2-il)benzensülfonamitten (sülfametizol) hareketle sentez edildi. Bütün yeni bileşiklerin yapıları elemental analiz ve çeşitli spektroskopik yöntemler (FTIR, 1H-NMR ve MS) yardımıyla aydınlatıldı. Bu yeni sülfonamit türevlerinin, özellikle insan karbonik anhidraz I ve II olmak üzere, karbonik anhidraz inhibitor etkileri incelendi. Bileşiklerin klinikte kullanılan asetazolamide kıyasla insan sitozolik CA I (IC50 değerleri 0.144-15.65 nM) ve CA II (IC50 değerleri 0.109-17.95 nM) inhibisyon değerleri ile daha yüksek aktivite gösterdikleri tespit edildi.

Özet

In the present study, N-(5-methyl-1,3,4-thiadiazol-2-yl)4-[(3-substituted)ureido]benzenesulfonamide (1-9) and N-(5-methyl-1,3,4-thiadiazol-2-yl)-4-[(3-substituted) thioureido]benzenesulfonamide (10-14) derivatives were synthesized from 4-amino-N-(5-methyl-1,3,4-thiadiazol-2-yl) benzenesulfonamide (sulfamethizole). All new compounds were characterized by elemental analysis and various spectroscopic methods (FTIR, 1H-NMR and MS). These new sulfonamide derivatives were investigated as inhibitors of carbonic anhydrase especially human carbonic anhydrase I and II. The new compounds showed higher activity against the human cytosolic CA I (IC50 values 0.144-15.65 nM) and CA II (IC50 values 0.10917.95 nM) in comparison with the clinically used CA inhibitor acetazolamide.

🔖

Cite This Article

TÜRK, S., TOK, F., ÇELİK, H., KARAKUŞ, S., NADAROĞLU, H., KAYMAKÇIOĞLU, B. K., KÜÇÜKOĞLU, K. (2017). Karbonik anhidraz I ve II inhibitörü olan bazı N-(5-metil1,3,4-tiyadiazol-2-il)-4-[(3-sübstitüe)üreido/tiyoüreido] benzensülfonamitler. Marmara Pharmaceutical Journal, Cilt: 21 - Sayı: 1, 89–95. https://ajindex.com/articles/283707

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Christensen GM, Olson D, Riedel B. Chemical effects on the activity of eight enzymes: A review and a discussion relevant to environmental monitoring. Environ Res 1982; 29: 247-55.
  2. Hoechster RM, Kates M, Questel JH. Metabolic inhibitors. Academic press 1973; 3-4: 71-89 and 66-82.
  3. Sly WS, Hu PY. Human carbonic anhydrases and carbonic anhydrase deficiencies. Annu Rev Biochem 1995; 64: 375-401.
  4. Rickli EE, Ghazantar SAS, Gibbons BH, Edsall JT. Carbonic anhydrase from human erythrocytes. J Biol Chem 1964; 239: 1065-78.
  5. Arslan O, Nalbantoglu B, Demir N, Ozdemir H, Kufrevioglu OI. A new method for the purification of carbonic anhydrase isoenzymes by affinity chromatography. Turk J Med Sci 1996; 26: 163-6.
  6. Supuran CT, Scozzafava A. Carbonic anhydrase inhibitors: Aromatic sulfonamides and disulfonamides act as efficient tumor growth inhibitors. Eur J Med Chem 2000; 35: 867-74.
  7. Ibrahim DA, Lasheen DS, Zaky MY, Ibrahim AW, Vullo D, Ceruso M, Supuran CT, Ella DA. Design and synthesis of benzothiazole-6-sulfonamides acting as highly potent inhibitors of carbonic anhydrase isoforms I, II, IX and XII. Bioorg Med Chem 2015; 23: 4989-99.
  8. Haapasalo J, Nordfords K, Järvelä S, Bragge H,Rantala I, Parkkila AK, Haapasalo H, Parkkila S. Carbonic anhydrase II in the endothelium of glial tumors: A potential target for therapy. Neuro Oncol 2007; 9: 308-13.
  9. Arslan A, Demir H, Arslan H. Investigating catalase and carbonic anhydrase enzyme activities and levels of certain trace elements and heavy metals in patients with primary and metastatic hepatic carcinoma. J Cancer Ther 2013; 4: 1373-81.
  10. Zolnowska B, Slawinski J, Pogorzelska A, Chojnacki J, Vullo D, Supuran CT. Carbonic anhydrase inhibitors: Synthesis, and molecular structure of novel series N-substituted-N’- (2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl) guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII. Eur J Med Chem 2014; 71: 135-47. Supuran CT. Diuretics: From classical carbonic anhydrase inhibitors to novel applications of the sulfonamides. Curr Pharm Design 2008; 14: 641-48. Supuran CT. Carbonic anydrases: Novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008; 7: 168-81.
  11. Hilvo M, Tolvanen M, Clark A, Shen BR, Shah GN, Waheed A, Halmi P, Hanninen M, Hamalainen JM, Vihinen M, Sly WS, Parkkila S. Characterization of CA XV, a new GPI-anchored form of carbonic anydrase. Biochem J 2005; 392: 83-92.
  12. Supuran CT, Scozz